The prognostic value of ERCC1 expression in gastric cancer patients treated with platinum-based chemotherapy: a meta-analysis.
about
Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy.Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer.Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer.Biomarkers to assess the efficiency of treatment with platinum-based drugs: what can metallomics add?Higher Expression of ERCC1 May Be Associated with Resistance to Adjuvant Platinum-Based Chemotherapy in Gastric Cancer.Prognostic Value of Excision Repair Cross-Complementing mRNA Expression in Gastric Cancer
P2860
The prognostic value of ERCC1 expression in gastric cancer patients treated with platinum-based chemotherapy: a meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The prognostic value of ERCC1 ...... chemotherapy: a meta-analysis.
@ast
The prognostic value of ERCC1 ...... chemotherapy: a meta-analysis.
@en
type
label
The prognostic value of ERCC1 ...... chemotherapy: a meta-analysis.
@ast
The prognostic value of ERCC1 ...... chemotherapy: a meta-analysis.
@en
prefLabel
The prognostic value of ERCC1 ...... chemotherapy: a meta-analysis.
@ast
The prognostic value of ERCC1 ...... chemotherapy: a meta-analysis.
@en
P2093
P2860
P1433
P1476
The prognostic value of ERCC1 ...... chemotherapy: a meta-analysis.
@en
P2093
Kong-Kong Wei
Quan-Lin Guan
Xuan-Kun Qian
Yao-Yao Wei
Yu-Feng Wang
P2860
P2888
P304
P356
10.1007/S13277-014-2128-1
P577
2014-05-29T00:00:00Z